Why Partner
Partner with the Inaugural Dark Genome Target Discovery & Development Summit
A Unique Opportunity to Learn Directly from Industry Pioneers
Uniting the fast-growing industry pioneers mining non-coding DNA, RNA and proteins, the inaugural Dark Genome Target Discovery & Development Summit, provides the opportunity to learn and gain insight from those navigating this complex and highly unknown area.
Meet with senior experts at ROME Therapeutics, Enara Bio, HAYA Therapeutics, HERVolution, CAMP4 Therapeutics, Immatics and more, to identify how you can support this community in driving novel target discovery, equipping robust validation, and facilitating drug development.
With 6+ hours of dedicated networking available, engage in meaningful conversations to learn how you can help this community drive novel target discovery, equip robust validation, and facilitate drug development. As a field still in its infancy, reach out today to discuss how you can play your part in unlocking the potential of the dark genome.
